Bernard Denoyer

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT.